Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Dr. Agarwal’s Health Care Ltd. ( (IN:AGARWALEYE) ) is now available.
Dr. Agarwal’s Health Care Ltd. has released its Monitoring Agency Report for the quarter ended June 30, 2025, prepared by ICRA Limited. This report, in compliance with SEBI regulations, details the utilization of proceeds from the company’s Initial Public Offer. While the report does not assess the quality or outcomes of the spending, it is a crucial document for stakeholders to understand the financial management and strategic direction of the company following its IPO.
More about Dr. Agarwal’s Health Care Ltd.
Dr. Agarwal’s Health Care Ltd. operates in the healthcare industry, focusing on providing medical services and products related to eye care. The company is known for its specialized services in ophthalmology and aims to expand its market presence through strategic initiatives.
Average Trading Volume: 20,875
Technical Sentiment Signal: Strong Buy
Current Market Cap: 142.2B INR
For an in-depth examination of AGARWALEYE stock, go to TipRanks’ Overview page.